Clinical Advisory Board expanded to support PromarkerD USA and global rollout

We are pleased to announce the appointment of additional members to the Clinical Advisory Board adding world leading healthcare professionals from the United States specialising in diabetes care and education.

The new members bring extensive experience experience and knowledge of diabetes care and and will provide valuable insights and guidance from the ‘voice of the customer’ (patients and clinicians) perspective to help successfully launch PromarkerD in the US and globally.

ASX Release